Skip to main content
. 2019 Mar 20;316(5):F1016–F1025. doi: 10.1152/ajprenal.00607.2018

Fig. 4.

Fig. 4.

A: representative bands (two per animal from a n = 7 per group) showing renal protein expression and quantification of VEGF, vascular endothelial growth factor; Flk-1, liver fetal kinase-1; Ang-1, angiopoietin-1; HGF, hepatocyte growth factor; HIF-1α, hypoxia-inducible factor-1α; SDF-1, stromal-derived factor-1; CXCR-4, chemokine receptor type 4 from normal, PTRAs and PTRAs+ELP-VEGF-treated kidneys. B: PTRAs followed by ELP-VEGF therapy improved renal expression of angiogenic factors and endothelial cell progenitor recruitment markers. †P < 0.05 versus RVD+PTRAs. *P < 0.05 versus Normal. #P = 0.06 versus RVD+PTRA. ^P = 0.06 versus Normal.